Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagit Weiss

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Neuroscience and Biobehavioral Reviews|April 15, 2014
Disability in multiple sclerosis: when synaptic long-term potentiation failsSagit Weiss, Francesco Mori, Silvia Rossi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 23, 2013
Cortical plasticity predicts recovery from relapse in multiple sclerosisFrancesco Mori, Hajime Kusayanagi, Carolina Gabri Nicoletti, et al.
Frontiers in Neurology|January 20, 2022
Safety and Tolerability, Dose-Escalating, Double-Blind Trial of Oral Mannitol in Parkinson's DiseaseEduard Linetsky, Suaad Abd Elhadi, Max Bauer, et al.
Journal of Neuroinflammation|February 20, 2014
Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosisSilvia Rossi, Valeria Studer, Caterina Motta, et al.
CNS Neuroscience & Therapeutics|May 20, 2014
Treatment options to reduce disease activity after natalizumab: paradoxical effects of corticosteroidsSilvia Rossi, Caterina Motta, Valeria Studer, et al.
Neuromolecular Medicine|March 28, 2014
Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosisFrancesco Mori, Carolina G Nicoletti, Silvia Rossi, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|February 2, 2013
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitisAntonietta Gentile, Silvia Rossi, Valeria Studer, et al.
Molecular Neurodegeneration|December 16, 2014
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53Silvia Rossi, Caterina Motta, Valeria Studer, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Neuroscience and Biobehavioral Reviews|April 15, 2014
Disability in multiple sclerosis: when synaptic long-term potentiation failsSagit Weiss, Francesco Mori, Silvia Rossi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 23, 2013
Cortical plasticity predicts recovery from relapse in multiple sclerosisFrancesco Mori, Hajime Kusayanagi, Carolina Gabri Nicoletti, et al.
Frontiers in Neurology|January 20, 2022
Safety and Tolerability, Dose-Escalating, Double-Blind Trial of Oral Mannitol in Parkinson's DiseaseEduard Linetsky, Suaad Abd Elhadi, Max Bauer, et al.
Journal of Neuroinflammation|February 20, 2014
Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosisSilvia Rossi, Valeria Studer, Caterina Motta, et al.
CNS Neuroscience & Therapeutics|May 20, 2014
Treatment options to reduce disease activity after natalizumab: paradoxical effects of corticosteroidsSilvia Rossi, Caterina Motta, Valeria Studer, et al.
Neuromolecular Medicine|March 28, 2014
Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosisFrancesco Mori, Carolina G Nicoletti, Silvia Rossi, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|February 2, 2013
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitisAntonietta Gentile, Silvia Rossi, Valeria Studer, et al.
Molecular Neurodegeneration|December 16, 2014
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53Silvia Rossi, Caterina Motta, Valeria Studer, et al.
Pageof 1